To find further support for TGF-β and JAK as modulators of ER pathway signaling in human breast cancer, we analyzed the transcriptional profile of all tumors classified as Luminal A or B in the BRCA dataset in TCGA. This evidence concerns the gene ESR1 and breast carcinoma.